Results 21 to 30 of about 2,905 (217)

A novel gene therapy for ARPKD based on CFTR

open access: hybridAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Autosomal recessive polycystic kidney disease is associated with cysts derived from abnormal bile ducts. We focused on targeting the cysts and show that a gene therapy for ARPKD that targets the abnormal bile ducts is feasible.
Cristian Ciobanu   +3 more
openalex   +2 more sources

c-myc antisense oligonucleotide treatment ameliorates murine ARPKD [PDF]

open access: bronzeKidney International, 2002
Overexpression of c-myc is postulated to play a role in the pathogenesis of polycystic kidney disease (PKD). c-myc expression is increased in all rodent models of PKD that have been examined as well as in human ADPKD. To determine whether overexpression of renal c-myc contributes to renal cyst formation, C57BL/6J-cpk litters (an animal model of ARPKD ...
Justin L. Ricker   +3 more
openalex   +3 more sources

EGF-related growth factors in the pathogenesis of murine ARPKD [PDF]

open access: bronzeKidney International, 2004
Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha) and their receptor, EGFR, play key roles in polycystic kidney disease (PKD) pathogenesis. Renal expression of two related growth factors, amphiregulin and heparin-binding EGF, has not been examined previously in PKD.
Katherine MacRae Dell   +3 more
openalex   +3 more sources

FPC in ARPKD [PDF]

open access: bronzeNature Reviews Nephrology, 2017
Susan J. Allison
openalex   +2 more sources

Autosomal Recessive Polycystic Kidney Disease in a Child Complicated by Autoimmune Hemolytic Anemia: A Case Report [PDF]

open access: yesPediatric Sciences Journal, 2023
Autosomal recessive polycystic kidney disease (ARPKD) is a rare genetic disorder that presents as an isolated polycystic renal disease in childhood, or associated with congenital hepatic fibrosis and/or Caroli disease.
Magd A. Kotb   +7 more
doaj   +1 more source

The genetics of autosomal recessive polycystic kidney disease (ARPKD).

open access: yesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
ARPKD is a genetically inherited kidney disease that manifests by bilateral enlargement of cystic kidneys and liver fibrosis. It shows a range of severity, with 30% of individuals dying early on and the majority having good prognosis if they survive the first year of life. The reasons for this variability remain unclear.
P. Goggolidou, T. Richards
semanticscholar   +3 more sources

Heart dysfunction in a rat model with autosomal recessive polycystic kidney disease. [PDF]

open access: yesJ Physiol
Abstract figure legend Our results demonstrate a diastolic dysfunction in animals with severe kidney disease. Moreover, chronic kidney disease (CKD)‐induced heart fibrosis and hypertrophy are associated with a dysregulation of cardiokine signalling in autosomal recessive polycystic kidney disease (ARPKD) animals. Created using BioRender.com.
Gayrard N   +11 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy